TAZ 抗体 (AA 1-100) (AbBy Fluor® 488)
Quick Overview for TAZ 抗体 (AA 1-100) (AbBy Fluor® 488) (ABIN1694960)
抗原
See all TAZ 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 1-100
-
交叉反应
- 人, 小鼠, 大鼠
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human TAZ
-
亚型
- IgG
-
-
anti-Tafazzin (TAZ) (AA 1-262) antibody
TAZ 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 1B10 unconjugated
anti-Tafazzin (TAZ) (AA 32-60) antibodyTAZ 适用: 人 WB, ELISA, IHC, FACS 宿主: 兔 Polyclonal unconjugated
anti-Tafazzin (TAZ) (AA 1-100) antibodyTAZ 适用: 人, 小鼠, 大鼠 WB, ELISA, IF (cc), IF (p), FACS, ICC, IHC (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-Tafazzin (TAZ) (AA 46-240) antibodyTAZ 适用: 小鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Tafazzin (TAZ) (AA 95-262) antibodyTAZ 适用: 人 ELISA, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Tafazzin (TAZ) (AA 154-292) antibodyTAZ 适用: 人 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Tafazzin (TAZ) (AA 32-60), (N-Term) antibodyTAZ 适用: 人 WB, FACS, IHC (p) 宿主: 兔 Polyclonal RB21836 unconjugated
anti-Tafazzin (TAZ) (AA 1-262) antibodyTAZ 适用: 人 ELISA, IF 宿主: 小鼠 Monoclonal 3C10 unconjugated
anti-Tafazzin (TAZ) (AA 46-239) antibodyTAZ 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Tafazzin (TAZ) (C-Term) antibodyTAZ 适用: 人 ELISA, IHC, IHC (p) 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
FCM 1:20-100
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- TAZ (Tafazzin (TAZ))
-
别名
- TAZ
-
背景
-
Synonyms: TAZ, WW domain-containing transcription regulator protein 1, Transcriptional coactivator with PDZ-binding motif, WWTR1
Background: Transcriptional coactivator which acts as a downstream regulatory target in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. WWTR1 enhances PAX8 and NKX2-1/TTF1-dependent gene activation. Regulates the nuclear accumulation of SMADS and has a key role in coupling them to the transcriptional machinery such as the mediator complex. Regulates embryonic stem-cell self-renewal, promotes cell proliferation and epithelial-mesenchymal transition.
-
基因ID
- 25937
-
UniProt
- Q9GZV5
抗原
-
